NVCR
29.01
-0.65 (-2.19%)
NovoCure Ltd. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website novocure.com
- Employees(FY) 1320
- ISIN JE00BYSS4X48
Performance
-3.56%
1W
+3.76%
1M
+97.08%
3M
+72.88%
6M
-2.65%
YTD
+95.29%
1Y
Profile
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. The company was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Technical Analysis of NVCR 2025-01-07
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-01-03 07:00
- 2025-01-02 18:00
- 2024-12-14 06:50
- 2024-12-06 08:32
Why NovoCure Stock Was Winning Big This Week(Motley Fool)
- 2024-12-05 04:29
- 2024-12-03 14:51
Novocure Stock Earns 96 RS Rating(Investor's Business Daily)
- 2024-12-03 09:56
- 2024-12-03 07:17
- 2024-12-02 16:23
Novocure Launches 49% After Pancreatic Cancer Treatment Succeeds(Investor's Business Daily)
- 2024-12-02 13:20
Novocure seeks approval after pancreatic cancer wearable scores at Phase III(Clinical Trials Arena)
- 2024-12-02 13:20
Novocure seeks approval after pancreatic cancer wearable scores at Phase III(Medical Device Network)
- 2024-12-02 12:09
- 2024-12-02 10:12
- 2024-12-02 09:54
- 2024-12-02 08:11
- 2024-12-02 08:09
Evercore ISI Upgrades NovoCure to Outperform(MT Newswires)
- 2024-12-02 07:02
- 2024-12-02 07:00
- 2024-12-02 06:08
- 2024-12-01 18:02
- 2024-12-01 18:00
- 2024-11-27 07:00
Novocure to Participate in Upcoming Investor Conferences(Business Wire)
- 2024-11-26 18:00
Novocure to Participate in Upcoming Investor Conferences(Businesswire)
- 2024-11-21 11:58
Novocure secures FDA approval for add-ons to brain cancer treatment wearable(Medical Device Network)
- 2024-11-21 08:37
NovoCure Gets FDA Nod for Updated Optune Gio Arrays(MT Newswires)
- 2024-11-21 07:05
- 2024-11-21 07:00
- 2024-11-20 18:05
- 2024-11-20 18:00
- 2024-10-31 07:30
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.